Examining Structurally Differentiated VENT-02 & Brain-Penetrant NLRP3 Inhibitor for Treatment of Neuroinflammatory Diseases

Time: 8:30 am
day: Day 1


  • Exploring the unique structural characteristics of VENT-02, a novel NLRP3 inhibitor designed for neuroinflammatory diseases
  • Investigating the potential of VENT-02 as a brain-penetrant therapeutic agent targeting the NLRP3 inflammasome
  • Assessing the preclinical data supporting the efficacy and safety profile of VENT-02 in treating neuroinflammatory conditions